glp-1 and migraine receptor agonists may have a role in chronic migraine, with a large real-world analysis showing lower healthcare utilization less need for additional medications over 1 year compared with topiramate. “ Could GLP-1s prevent migraine? A

Primary candidates include patients with type 2 diabetes and established cardiovascular disease, those with multiple cardiovascular risk factors including dyslipidemia, and adults with obesity or overweight with weight-related comorbidities

Get Started Today Want to Schedule an Appointment or Ask a Question

And for patients, it helps them manage their condition better

While information on employer plan formularies is not publicly available, these plans may be more likely to cover drugs for weight loss than ACA Marketplace plans given the desire to attract workers, though they may employ similar utilization management strategies.

GLP-1 medications like liraglutide (Saxenda and Victoza), semaglutide (Wegovy or Ozempic), and tirzepatide (Mounjaro or Zepbound) mimic a hormone thats naturally produced by the body

Riluzole is a glutamate antagonist and is used to treat myotrophic lateral sclerosis (ALS)